2Komers R,Allen TJ,Cooper ME.Role of endothelium dependent nitric oxide in the Pathogenesis of the renal hemodynarnic changes of experimental diabetes.Diabetes,1994,43(10):1 190.
3Shultz PJ,schorer AE,Raij I.Effects of endothelium Derived relaxing factor and nitric oxide on rat mesangial Cell.Am J Physiol,1990,258(1):162.
4Chiarelli F,Cipollone F,Romano F,et al.Increased Circulation nitric oxide in young patients with type 1 diabetes And persistent microalbuminuria:relation to glomerular.Hyperfiltration Diabetes,2000,49(7):1 258.
6Wascher TC,Graier WF,Bahadori B.Time couuse of endothelial dysfunction in diabetic mellitus.Circulation,2000,49(5):857.
二级参考文献23
1Kwon G, Xu G, Marshall CA, et al. Tumor necrosis factor α-induced pancreatic β-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-δ12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor γ activation and inos expression. J Biol Chem, 1999,274:18702-18708.
2Henningsson R, Salehi A, Lundquist I. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release. Am J Physiol Cell Physiol, 2002,283:C296-304.
3Cook S, Scherrer U. Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam Clin Pharmacol, 2002,16:441-453.
4Panaro MA, Brandonisio O, Acquafredda A, et al. Evidences for iNOS expression and nitric oxide production in the human macrophages. Curr Drug Targets Immune Endocr Metabol Disord, 2003,3:210-221.
5Henningsson R, Alm P, Lindstrom E, et al. Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release. Am J Physiol Endocrinol Metab, 2000,279:E95-E107.
6Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide, 1997,1:107-120.
7Kurrek MM, Zapol WM, Holzmann A, et al. In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated-perfused rat lung. Am J Physiol, 1995,269:L618-L624.
8Ribiere C, Jaubert AM, Gaudiot N, et al. White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun, 1996,222:706-712.
9Kapur S, Bedard S, Marcotte B, et al. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes, 1997,46:1691-1700.
10Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med, 2001,7:1138-1143.
3J. D. Rippin Dr.,A. Patel,N. D. Belyaev,G. V. Gill,A. H. Barnett,S. C. Bain.Nitric oxide synthase gene polymorphisms and diabetic nephropathy[J].Diabetologia.2003(3)
4Y. Ohtomo,A. Aperia,B. Sahlgren,B. -L. Johansson,Professor J. Wahren.C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y[J].Diabetologia.1996(2)
5B. -L. Johansson,S. Sj?berg,J. Wahren.The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients[J].Diabetologia.1992(2)
6IdoY,Vindigni A,Chang K,et al.Prevention of vascular and neural dysfunction in diabetic rats by C-peptide[].Science.1997
8Johansson B L,Kernell A,Sjoberg S,et al.Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1[].Journal of Clinical Endocrinology and Metabolism.1993
9Samnegard B,Jacobson S H,Jaremko G,et al.Effects of C-peptide on glomerular and renal size and renal function in diabetic rats[].Kidney International.2001
10Kone BC.Localization and regulation of nitric oxide synthase isoforms in the kidney[].Seminars in Nephrology.1999
